News

Teva Pharmaceutical Industries Limited (TEVA) Study Finds Gaps in Tardive Dyskinesia Care at Long-Term Facilities
A new study from Teva Pharmaceutical Industries Limited (NYSE:TEVA) has uncovered alarming gaps in the diagnosis and ...
Asthma drug could help to treat a rare neurological disorder
The asthma medication theophylline is a suitable drug for treating the rare neurological disorder ADCY5-related dyskinesia, ...
Nasdaq6d
Teva Study Highlights Gaps In Tardive Dyskinesia Diagnosis And Treatment In LTC Facilities
(RTTNews) - Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced results from a study of treatment patterns among patients with tardive dyskinesia (TD ...
Nasdaq7d
Teva Pharmaceuticals Highlights Critical Treatment Gaps for Tardive Dyskinesia in Long-Term Care Facilities
Study reveals over half of long-term care residents with tardive dyskinesia do not receive standard treatment, highlighting care gaps. Less than half of patients diagnosed with tardive dyskinesia ...
MedPage Today9d
Video: Raising Awareness About Tardive Dyskinesia
According to new research, oral vertical dyskinesia (OVD), also known by the older term “rabbit syndrome,” may be part of a spectrum of symptoms of drug-induced parkinsonism and tardive ...
MedPage Today9d
Video: Teamwork In Tardive Dyskinesia Care
Tardive dyskinesia can be permanent, even with a relatively short exposure, notes Winona Tse, MD, professor of neurology at the Icahn School of Medicine in New York City, which is why raising ...
BlackDoctor.org2d
5 Leading Therapies for TD
Living with TD? Let’s dive into the top five leading therapies for tardive dyskinesia you’ve probably never even heard ...
Videra Health Launches TDScreen, a First-of-Its-Kind Video-based, AI-powered Tool to Assess Tardive Dyskinesia Symptoms
New study published in the Journal of Clinical Psychiatry reveals AI enables efficient, accurate and scalable detection of TD, representing a significant advancement in meeting the standard of care ...
Technology Networks4d
Asthma Drug Reduces Movement Disorder Symptoms
Research from Martin Luther University suggests the asthma drug theophylline helps reduce symptoms in ADCY5-related ...
Morningstar7d
New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025
More than half of residents with tardive dyskinesia (TD) residing in long-term care (LTC) settings do not receive standard of care treatment, and one-quarter are left untreated LTC residents are ...
Financial Post6d
New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025
More than half of residents with tardive dyskinesia (TD) residing in long-term care (LTC) settings do not receive standard of care treatment, and one-quarter are left untreated LTC residents are often ...
Teva Study Highlights Gaps In Tardive Dyskinesia Diagnosis And Treatment In LTC Facilities
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (TEVA), announced results from a study of treatment patterns among patients with tardive dyskinesia ...